Push back on Trump's plan to restrict uses for NIH grants
Business leaders in the North Country are sounding the alarm over a plan from the Trump administration to cap administrative costs for grants awarded by the National Institutes of Health, money used to research medical advancements and fund operations at facilities across New York.
In a letter sent to New York's congressional delegation, the Business Council of New York, the Long Island Association, the Buffalo Niagara Partnership and various regional chambers of commerce said the proposed cap of 15% on administrative costs that can be paid for with NIH grants would decimate New York's research facilities.
In the North Country, NIH grants fund tuberculosis and infectious disease research at the Trudeau Institute in Saranac Lake and cancer research at Clarkson University.
'They really rely on NIH funding for them to be able to do that research, which is leading to vaccines and treatments for these diseases,' said Joel Wood, vice president of strategic initiatives for the North Country Chamber of Commerce.
Statewide, more than 250 research organizations receive more than $3.5 billion in NIH grant funding each year. New York is the second-largest recipient of NIH grant funding, second only to California.
Data on how research groups use their NIH grants isn't immediately available, and tends to vary between grant years, but on average historically, research institutions have agreed to use between 25% to 30% of their grant funding for indirect costs, like facility maintenance, administrative operations and other tertiary costs incurred by running a research program.
If capped at 15%, researchers have argued they would be unable to effectively operate their programs and would have to pare down their operations or close entirely. The Greater New York Hospital Association estimates that up to $850 million in state research funding could be pulled if the cap is kept in place, and the State University of New York would lose $7 million in funding.
Besides the economic impact of the lost funding, which would mean fewer high-paying research positions in upstate communities, state business leaders are worried about the long-term effects of stalled health research on the economy.
'When people are healthy, they can work, and when people are sick they can't,' Wood said. 'That's a major economic driver, keeping people healthy is going to result in a healthy workforce that can generate economic activity. If we don't remain at the cutting edge of this research, we're going to see health issues become more widespread.'
In their letter to New York's Republican and Democratic lawmakers, the state business community asked that the lawmakers stand with the business community and oppose the 15% cap on administrative costs for NIH grants, and maintain the status quo.
'We are hopeful that you will be a steadfast advocate for protecting these critical programs that support both our economy and the health of our workforce,' the letter closes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
3 hours ago
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
ALBANY, N.Y. -- Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation. The New York Senate gave final approval to the bill Monday night after hours of debate during which supporters said it would let terminally ill people die on their own terms. 'It's not about hastening death, but ending suffering,' said state Sen. Brad Hoylman-Sigal, a Democrat who sponsored the proposal. Opponents have argued the state should instead improve end-of-life medical care or have objected on religious grounds. 'We should not be in the business of state-authorized suicide,' said state Sen. George Borrello, a Republican. The state Assembly passed the measure in late April. The proposal requires that a terminally ill person who is expected to die within six month make a written request for the drugs. Two witnesses would have sign the request to ensure that the patient is not being coerced. The request would then have to be approved by the person's attending physician as well as a consulting physician. The legislation was first introduced in 2016, Hoylman-Sigal said, though it has stalled year after year in the New York statehouse. Dennis Poust, executive director of the New York State Catholic Conference, which has opposed the measure, said 'This is a dark day for New York State." Eleven other states and Washington, D.C., have laws allowing medically assisted suicide, according to Compassion & Choices, an advocacy organization that backs the policy. Corinne Carey, the group's local campaign director, said lawmakers had 'recognized how important it is to give terminally ill New Yorkers the autonomy they deserve over their own end-of-life experiences.' 'The option of medical aid in dying provides comfort, allowing those who are dying to live their time more fully and peacefully until the end,' said Carey.
Yahoo
4 hours ago
- Yahoo
US Health Secretary Kennedy guts vaccine advisory committee
By Ahmed Aboulenein, Michael Erman and Julie Steenhuysen WASHINGTON (Reuters) -Health Secretary Robert F. Kennedy Jr. has fired all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is in the process of replacing them, his department said on Monday, drawing protest from many vaccine scientists. The move is the most far-reaching in a series of actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. Scientists and experts said the changes to the vaccine panel, which recommends how vaccines are used and by whom, would undermine public confidence in health agencies. Kennedy promised the move would raise public confidence. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in a statement from the Department of Health and Human Services. Kennedy has for years sown doubt about the safety and efficacy of vaccines, but he pledged to maintain the country's existing vaccine standards to secure his appointment in President Donald Trump's administration. The Food and Drug Administration, which is overseen by Kennedy's department, has approved a number of vaccines during his tenure despite concerns over his stances. Even so, at least one senior Republican member of Congress expressed doubts about the changes in the panel. Kennedy said the Advisory Committee on Immunization Practices is rife with conflicts and has never turned down a vaccine, even though the decision to approve vaccines rests with the U.S. Food and Drug Administration. The CDC panel provides guidance to the CDC on which groups of people would most benefit from an already-approved vaccine. "That's a tragedy," said former FDA Chief Scientist Jesse Goodman. "This is a highly professional group of scientists and physicians and others... It's the kind of political meddling that will reduce confidence rather than increase confidence." The Pharmaceutical Research and Manufacturers of America called Kennedy's action concerning for public health. "Upending the ACIP membership increases uncertainty and vaccine skepticism, undermining the health gains achieved through vaccination," the industry body said in a statement late on Monday. Shares of vaccine makers Moderna and U.S.-listed shares of BioNTech fell more than 1%, while Pfizer was down marginally in extended trading on Monday. Kennedy said most panel members receive funding from drugmakers although members are required to declare any potential or perceived conflicts of interest that arise in the course of their tenure and any relevant business interests, positions of authority or other connections with organizations relevant to the committee's work. Kennedy and HHS provided no specific evidence of industry conflicts of interest among departing ACIP members. The CDC's web page for conflicts of interest, last updated in March, showed that one current member had recused herself from votes on a handful of vaccines because she had worked on clinical trials for their manufacturers. BIDEN APPOINTEES All 17 ACIP members were appointed under former President Joe Biden's administration, including 13 in 2024, HHS said. Without their removal, Trump's administration would not have been able to choose a majority of the committee until 2028. "This is not a political committee, it's never been partisan," said Dorit Reiss, a vaccine law expert at UC Law San Francisco. "It's an expert committee. Presidents have never been involved in ACIP membership." The decision drew criticism from Democrats in Congress, and one key Republican expressed concern. "Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion," said Republican U.S. Senator Bill Cassidy in a post on X. "I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case." Cassidy, a doctor from Louisiana who had expressed wariness about Kennedy's anti-vaccine views before clearing the path for him to become the nation's top health official, said at the time he had received assurances Kennedy would protect existing vaccination programs. The CDC panel will convene its next meeting June 25-27 at CDC headquarters in Atlanta, the department said. Vetting new panel members typically takes months, said one expert with close ties to the committee, who expressed doubts the newly appointed panel would be able to meet on time unless Kennedy and his team "have been working in the shadows" to onboard them months ahead of the announcement. Kennedy has drawn condemnation from health officials for his vaccine policies including what they say is a weak endorsement of the measles shots during an outbreak that has infected more than 1,000 mostly unvaccinated people and killed three. He announced last month the government was dropping its recommendation that healthy children and pregnant women should receive COVID shots, sidestepping the typical process. Traditionally, once the FDA approves vaccines for sale to the public, ACIP's role is to review data in a public meeting and vote on vaccine recommendations, which are then sent to the CDC director to sign off. The Affordable Care Act generally requires insurers to cover vaccines that are listed on the CDC vaccine schedules for adults and children. The recommendations also determine which vaccines the CDC's Vaccines for Children program will provide free of charge to those without insurance.
Yahoo
5 hours ago
- Yahoo
Nevada health bill advances to Gov. Lombardo's desk
LAS VEGAS (KLAS) – Health bill SB 217 advanced in the Nevada legislature last week and is now on Governor Lombardo's desk awaiting his signature. The bill includes coverage for treatments like IVF, as well as fertility preservation for those who have been diagnosed with extreme illness. 'I had arthritis for most of my life. That drug that I was on, while helpful to my arthritis, was severely damaging to my egg reserves,' shared Stephanie Capellas-Glascock, who has been struggling with her infertility journey for years. 'I knew that it wasn't going to be something that I could accomplish on my own, so therefore I needed to look into fertility treatments for myself,' she explained. If signed, Nevada could become the first state in the nation to offer fertility coverage for Medicaid. However, the bill does face pushback for its cost and certain language in it. 'One of my concerns, just looking at it, so I may reserve my right to change my vote, is just the financial impact on our public employee benefit program that can go down to increasing premiums,' said Democratic Assembly Member Shea Backus, who did vote in favor. Meanwhile, the Nevada GOP party called on the governor to veto the bill. Their website cited their opposition because it 'declares embryos prior to implantation as non-human.' 'I don't think fertility treatments are a political issue. I think it's a health and medical issue,' Capellas-Glascock responded when asked about the opposition. 'We know that the GOP has some thoughts and feelings on that too, but I think the tremendous thing about IVF is that it is a miracle in medicine and science that really affords individuals the option to have a family, so when they're ready to start a family, they have that option.' When asked about the fiscal implications, she responded, 'There's always a cost associated. I think it's knowing that the pros supremely outweigh the cons.' The state estimated the cost would be about $38 million over the next two years. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
